nodes	percent_of_prediction	percent_of_DWPC	metapath
Benazepril—Lisinopril—systemic scleroderma	0.328	1	CrCtD
Benazepril—ACE—systemic scleroderma	0.175	1	CbGaD
Benazepril—ACE—Lisinopril—systemic scleroderma	0.0746	0.356	CbGbCtD
Benazepril—Enalapril—Captopril—systemic scleroderma	0.0658	0.296	CrCrCtD
Benazepril—ACE—Captopril—systemic scleroderma	0.0559	0.267	CbGbCtD
Benazepril—SLC15A1—Lisinopril—systemic scleroderma	0.0299	0.143	CbGbCtD
Benazepril—Moexipril—Lisinopril—systemic scleroderma	0.0268	0.12	CrCrCtD
Benazepril—MTHFR—Methotrexate—systemic scleroderma	0.0265	0.127	CbGbCtD
Benazepril—Cilazapril—Lisinopril—systemic scleroderma	0.0231	0.104	CrCrCtD
Benazepril—Spirapril—Lisinopril—systemic scleroderma	0.0231	0.104	CrCrCtD
Benazepril—SLC15A1—Captopril—systemic scleroderma	0.0224	0.107	CbGbCtD
Benazepril—Ramipril—Lisinopril—systemic scleroderma	0.0217	0.0976	CrCrCtD
Benazepril—Enalapril—Lisinopril—systemic scleroderma	0.0217	0.0976	CrCrCtD
Benazepril—Trandolapril—Lisinopril—systemic scleroderma	0.0217	0.0976	CrCrCtD
Benazepril—Quinapril—Lisinopril—systemic scleroderma	0.0184	0.0827	CrCrCtD
Benazepril—ACE—forelimb zeugopod—systemic scleroderma	0.00352	0.192	CbGeAlD
Benazepril—ACE—pulmonary artery—systemic scleroderma	0.00264	0.144	CbGeAlD
Benazepril—ACE—skeletal joint—systemic scleroderma	0.00233	0.127	CbGeAlD
Benazepril—ACE—umbilical vein—systemic scleroderma	0.00174	0.0949	CbGeAlD
Benazepril—MTHFR—artery—systemic scleroderma	0.0016	0.0871	CbGeAlD
Benazepril—MTHFR—blood vessel—systemic scleroderma	0.00125	0.0679	CbGeAlD
Benazepril—ACE—artery—systemic scleroderma	0.000977	0.0532	CbGeAlD
Benazepril—ACE—endothelium—systemic scleroderma	0.000826	0.045	CbGeAlD
Benazepril—ACE—blood vessel—systemic scleroderma	0.000761	0.0415	CbGeAlD
Benazepril—MTHFR—digestive system—systemic scleroderma	0.000462	0.0251	CbGeAlD
Benazepril—SLC15A1—digestive system—systemic scleroderma	0.000393	0.0214	CbGeAlD
Benazepril—ACE—connective tissue—systemic scleroderma	0.00039	0.0213	CbGeAlD
Benazepril—MTHFR—lung—systemic scleroderma	0.000385	0.021	CbGeAlD
Benazepril—ACE—smooth muscle tissue—systemic scleroderma	0.000357	0.0195	CbGeAlD
Benazepril—ACE—digestive system—systemic scleroderma	0.000282	0.0154	CbGeAlD
Benazepril—ACE—lung—systemic scleroderma	0.000235	0.0128	CbGeAlD
Benazepril—Spirapril—ACE—systemic scleroderma	0.000217	0.143	CrCbGaD
Benazepril—Moexipril—ACE—systemic scleroderma	0.000208	0.137	CrCbGaD
Benazepril—SLC15A2—lung—systemic scleroderma	0.000205	0.0112	CbGeAlD
Benazepril—Lisinopril—ACE—systemic scleroderma	0.000194	0.127	CrCbGaD
Benazepril—Cilazapril—ACE—systemic scleroderma	0.000194	0.127	CrCbGaD
Benazepril—Quinapril—ACE—systemic scleroderma	0.000194	0.127	CrCbGaD
Benazepril—Trandolapril—ACE—systemic scleroderma	0.000187	0.123	CrCbGaD
Benazepril—Ramipril—ACE—systemic scleroderma	0.000187	0.123	CrCbGaD
Benazepril—Enalapril—ACE—systemic scleroderma	0.000142	0.0932	CrCbGaD
Benazepril—Arthralgia—Mycophenolic acid—systemic scleroderma	6.39e-05	0.00142	CcSEcCtD
Benazepril—Infection—Leflunomide—systemic scleroderma	6.38e-05	0.00142	CcSEcCtD
Benazepril—Gastrointestinal pain—Captopril—systemic scleroderma	6.37e-05	0.00142	CcSEcCtD
Benazepril—Anxiety—Mycophenolic acid—systemic scleroderma	6.37e-05	0.00142	CcSEcCtD
Benazepril—Asthenia—Mometasone—systemic scleroderma	6.36e-05	0.00142	CcSEcCtD
Benazepril—Hypotension—Azathioprine—systemic scleroderma	6.35e-05	0.00141	CcSEcCtD
Benazepril—Photosensitivity—Methotrexate—systemic scleroderma	6.35e-05	0.00141	CcSEcCtD
Benazepril—Tinnitus—Mycophenolate mofetil—systemic scleroderma	6.34e-05	0.00141	CcSEcCtD
Benazepril—Thrombocytopenia—Leflunomide—systemic scleroderma	6.29e-05	0.0014	CcSEcCtD
Benazepril—Pruritus—Mometasone—systemic scleroderma	6.28e-05	0.0014	CcSEcCtD
Benazepril—Hyperhidrosis—Leflunomide—systemic scleroderma	6.21e-05	0.00138	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	6.2e-05	0.00138	CcSEcCtD
Benazepril—Angioedema—Lisinopril—systemic scleroderma	6.18e-05	0.00138	CcSEcCtD
Benazepril—Abdominal pain—Captopril—systemic scleroderma	6.16e-05	0.00137	CcSEcCtD
Benazepril—Oedema—Mycophenolic acid—systemic scleroderma	6.13e-05	0.00136	CcSEcCtD
Benazepril—Nausea—Pentoxifylline—systemic scleroderma	6.11e-05	0.00136	CcSEcCtD
Benazepril—Infection—Mycophenolic acid—systemic scleroderma	6.09e-05	0.00135	CcSEcCtD
Benazepril—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	6.08e-05	0.00135	CcSEcCtD
Benazepril—Vertigo—Lisinopril—systemic scleroderma	6.07e-05	0.00135	CcSEcCtD
Benazepril—Diarrhoea—Mometasone—systemic scleroderma	6.07e-05	0.00135	CcSEcCtD
Benazepril—Syncope—Lisinopril—systemic scleroderma	6.06e-05	0.00135	CcSEcCtD
Benazepril—Leukopenia—Lisinopril—systemic scleroderma	6.05e-05	0.00135	CcSEcCtD
Benazepril—Shock—Mycophenolic acid—systemic scleroderma	6.03e-05	0.00134	CcSEcCtD
Benazepril—Alopecia—Mycophenolate mofetil—systemic scleroderma	6.01e-05	0.00134	CcSEcCtD
Benazepril—Hypotension—Leflunomide—systemic scleroderma	6e-05	0.00134	CcSEcCtD
Benazepril—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	6e-05	0.00134	CcSEcCtD
Benazepril—Palpitations—Lisinopril—systemic scleroderma	5.97e-05	0.00133	CcSEcCtD
Benazepril—Loss of consciousness—Lisinopril—systemic scleroderma	5.94e-05	0.00132	CcSEcCtD
Benazepril—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	5.92e-05	0.00132	CcSEcCtD
Benazepril—Cough—Lisinopril—systemic scleroderma	5.9e-05	0.00131	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	5.85e-05	0.0013	CcSEcCtD
Benazepril—Flatulence—Mycophenolate mofetil—systemic scleroderma	5.84e-05	0.0013	CcSEcCtD
Benazepril—Tension—Mycophenolate mofetil—systemic scleroderma	5.81e-05	0.00129	CcSEcCtD
Benazepril—Insomnia—Leflunomide—systemic scleroderma	5.81e-05	0.00129	CcSEcCtD
Benazepril—Paraesthesia—Leflunomide—systemic scleroderma	5.77e-05	0.00128	CcSEcCtD
Benazepril—Anaphylactoid reaction—Methotrexate—systemic scleroderma	5.76e-05	0.00128	CcSEcCtD
Benazepril—Myalgia—Lisinopril—systemic scleroderma	5.76e-05	0.00128	CcSEcCtD
Benazepril—Arthralgia—Lisinopril—systemic scleroderma	5.76e-05	0.00128	CcSEcCtD
Benazepril—Chest pain—Lisinopril—systemic scleroderma	5.76e-05	0.00128	CcSEcCtD
Benazepril—Nervousness—Mycophenolate mofetil—systemic scleroderma	5.75e-05	0.00128	CcSEcCtD
Benazepril—Anxiety—Lisinopril—systemic scleroderma	5.74e-05	0.00128	CcSEcCtD
Benazepril—Back pain—Mycophenolate mofetil—systemic scleroderma	5.73e-05	0.00128	CcSEcCtD
Benazepril—Dyspnoea—Leflunomide—systemic scleroderma	5.73e-05	0.00127	CcSEcCtD
Benazepril—Hypotension—Mycophenolic acid—systemic scleroderma	5.72e-05	0.00127	CcSEcCtD
Benazepril—Cerebrovascular accident—Methotrexate—systemic scleroderma	5.69e-05	0.00127	CcSEcCtD
Benazepril—Dyspepsia—Leflunomide—systemic scleroderma	5.65e-05	0.00126	CcSEcCtD
Benazepril—Pancreatitis—Prednisone—systemic scleroderma	5.65e-05	0.00126	CcSEcCtD
Benazepril—Vomiting—Mometasone—systemic scleroderma	5.64e-05	0.00126	CcSEcCtD
Benazepril—Rash—Mometasone—systemic scleroderma	5.59e-05	0.00125	CcSEcCtD
Benazepril—Asthenia—Captopril—systemic scleroderma	5.59e-05	0.00124	CcSEcCtD
Benazepril—Dermatitis—Mometasone—systemic scleroderma	5.59e-05	0.00124	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	5.58e-05	0.00124	CcSEcCtD
Benazepril—Gastrointestinal pain—Azathioprine—systemic scleroderma	5.56e-05	0.00124	CcSEcCtD
Benazepril—Headache—Mometasone—systemic scleroderma	5.56e-05	0.00124	CcSEcCtD
Benazepril—Insomnia—Mycophenolic acid—systemic scleroderma	5.54e-05	0.00123	CcSEcCtD
Benazepril—Fatigue—Leflunomide—systemic scleroderma	5.54e-05	0.00123	CcSEcCtD
Benazepril—Oedema—Lisinopril—systemic scleroderma	5.52e-05	0.00123	CcSEcCtD
Benazepril—Anaphylactic shock—Lisinopril—systemic scleroderma	5.52e-05	0.00123	CcSEcCtD
Benazepril—Pruritus—Captopril—systemic scleroderma	5.51e-05	0.00123	CcSEcCtD
Benazepril—Paraesthesia—Mycophenolic acid—systemic scleroderma	5.5e-05	0.00122	CcSEcCtD
Benazepril—Constipation—Leflunomide—systemic scleroderma	5.49e-05	0.00122	CcSEcCtD
Benazepril—Infection—Lisinopril—systemic scleroderma	5.48e-05	0.00122	CcSEcCtD
Benazepril—Dyspnoea—Mycophenolic acid—systemic scleroderma	5.46e-05	0.00122	CcSEcCtD
Benazepril—Somnolence—Mycophenolic acid—systemic scleroderma	5.45e-05	0.00121	CcSEcCtD
Benazepril—Shock—Lisinopril—systemic scleroderma	5.43e-05	0.00121	CcSEcCtD
Benazepril—Angioedema—Mycophenolate mofetil—systemic scleroderma	5.41e-05	0.0012	CcSEcCtD
Benazepril—Thrombocytopenia—Lisinopril—systemic scleroderma	5.4e-05	0.0012	CcSEcCtD
Benazepril—Dyspepsia—Mycophenolic acid—systemic scleroderma	5.39e-05	0.0012	CcSEcCtD
Benazepril—Neutropenia—Prednisone—systemic scleroderma	5.39e-05	0.0012	CcSEcCtD
Benazepril—Abdominal pain—Azathioprine—systemic scleroderma	5.38e-05	0.0012	CcSEcCtD
Benazepril—Hyperhidrosis—Lisinopril—systemic scleroderma	5.33e-05	0.00119	CcSEcCtD
Benazepril—Diarrhoea—Captopril—systemic scleroderma	5.33e-05	0.00119	CcSEcCtD
Benazepril—Vertigo—Mycophenolate mofetil—systemic scleroderma	5.32e-05	0.00118	CcSEcCtD
Benazepril—Syncope—Mycophenolate mofetil—systemic scleroderma	5.31e-05	0.00118	CcSEcCtD
Benazepril—Erectile dysfunction—Prednisone—systemic scleroderma	5.31e-05	0.00118	CcSEcCtD
Benazepril—Leukopenia—Mycophenolate mofetil—systemic scleroderma	5.3e-05	0.00118	CcSEcCtD
Benazepril—Fatigue—Mycophenolic acid—systemic scleroderma	5.28e-05	0.00118	CcSEcCtD
Benazepril—Nausea—Mometasone—systemic scleroderma	5.27e-05	0.00117	CcSEcCtD
Benazepril—Gastrointestinal pain—Leflunomide—systemic scleroderma	5.25e-05	0.00117	CcSEcCtD
Benazepril—Constipation—Mycophenolic acid—systemic scleroderma	5.24e-05	0.00117	CcSEcCtD
Benazepril—Palpitations—Mycophenolate mofetil—systemic scleroderma	5.23e-05	0.00117	CcSEcCtD
Benazepril—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	5.21e-05	0.00116	CcSEcCtD
Benazepril—Cough—Mycophenolate mofetil—systemic scleroderma	5.17e-05	0.00115	CcSEcCtD
Benazepril—Hypotension—Lisinopril—systemic scleroderma	5.16e-05	0.00115	CcSEcCtD
Benazepril—Dizziness—Captopril—systemic scleroderma	5.15e-05	0.00115	CcSEcCtD
Benazepril—Abdominal pain—Leflunomide—systemic scleroderma	5.08e-05	0.00113	CcSEcCtD
Benazepril—Acute coronary syndrome—Prednisone—systemic scleroderma	5.07e-05	0.00113	CcSEcCtD
Benazepril—Chest pain—Mycophenolate mofetil—systemic scleroderma	5.04e-05	0.00112	CcSEcCtD
Benazepril—Myalgia—Mycophenolate mofetil—systemic scleroderma	5.04e-05	0.00112	CcSEcCtD
Benazepril—Arthralgia—Mycophenolate mofetil—systemic scleroderma	5.04e-05	0.00112	CcSEcCtD
Benazepril—Myocardial infarction—Prednisone—systemic scleroderma	5.04e-05	0.00112	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	5.03e-05	0.00112	CcSEcCtD
Benazepril—Anxiety—Mycophenolate mofetil—systemic scleroderma	5.03e-05	0.00112	CcSEcCtD
Benazepril—Hypersensitivity—Azathioprine—systemic scleroderma	5.01e-05	0.00112	CcSEcCtD
Benazepril—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	5.01e-05	0.00112	CcSEcCtD
Benazepril—Insomnia—Lisinopril—systemic scleroderma	4.99e-05	0.00111	CcSEcCtD
Benazepril—Paraesthesia—Lisinopril—systemic scleroderma	4.95e-05	0.0011	CcSEcCtD
Benazepril—Vomiting—Captopril—systemic scleroderma	4.95e-05	0.0011	CcSEcCtD
Benazepril—Dyspnoea—Lisinopril—systemic scleroderma	4.92e-05	0.0011	CcSEcCtD
Benazepril—Rash—Captopril—systemic scleroderma	4.91e-05	0.00109	CcSEcCtD
Benazepril—Dermatitis—Captopril—systemic scleroderma	4.91e-05	0.00109	CcSEcCtD
Benazepril—Somnolence—Lisinopril—systemic scleroderma	4.91e-05	0.00109	CcSEcCtD
Benazepril—Headache—Captopril—systemic scleroderma	4.88e-05	0.00109	CcSEcCtD
Benazepril—Dyspepsia—Lisinopril—systemic scleroderma	4.86e-05	0.00108	CcSEcCtD
Benazepril—Abdominal pain—Mycophenolic acid—systemic scleroderma	4.84e-05	0.00108	CcSEcCtD
Benazepril—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	4.83e-05	0.00108	CcSEcCtD
Benazepril—Oedema—Mycophenolate mofetil—systemic scleroderma	4.83e-05	0.00108	CcSEcCtD
Benazepril—Asthma—Methotrexate—systemic scleroderma	4.82e-05	0.00107	CcSEcCtD
Benazepril—Infection—Mycophenolate mofetil—systemic scleroderma	4.8e-05	0.00107	CcSEcCtD
Benazepril—Eosinophilia—Methotrexate—systemic scleroderma	4.77e-05	0.00106	CcSEcCtD
Benazepril—Fatigue—Lisinopril—systemic scleroderma	4.76e-05	0.00106	CcSEcCtD
Benazepril—Shock—Mycophenolate mofetil—systemic scleroderma	4.76e-05	0.00106	CcSEcCtD
Benazepril—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	4.73e-05	0.00105	CcSEcCtD
Benazepril—Hypersensitivity—Leflunomide—systemic scleroderma	4.73e-05	0.00105	CcSEcCtD
Benazepril—Pancreatitis—Methotrexate—systemic scleroderma	4.72e-05	0.00105	CcSEcCtD
Benazepril—Constipation—Lisinopril—systemic scleroderma	4.72e-05	0.00105	CcSEcCtD
Benazepril—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	4.67e-05	0.00104	CcSEcCtD
Benazepril—Diarrhoea—Azathioprine—systemic scleroderma	4.65e-05	0.00104	CcSEcCtD
Benazepril—Nausea—Captopril—systemic scleroderma	4.63e-05	0.00103	CcSEcCtD
Benazepril—Asthenia—Leflunomide—systemic scleroderma	4.61e-05	0.00103	CcSEcCtD
Benazepril—Pruritus—Leflunomide—systemic scleroderma	4.54e-05	0.00101	CcSEcCtD
Benazepril—Hypotension—Mycophenolate mofetil—systemic scleroderma	4.52e-05	0.00101	CcSEcCtD
Benazepril—Gastrointestinal pain—Lisinopril—systemic scleroderma	4.51e-05	0.001	CcSEcCtD
Benazepril—Neutropenia—Methotrexate—systemic scleroderma	4.5e-05	0.001	CcSEcCtD
Benazepril—Dizziness—Azathioprine—systemic scleroderma	4.5e-05	0.001	CcSEcCtD
Benazepril—Erectile dysfunction—Methotrexate—systemic scleroderma	4.44e-05	0.000987	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	4.4e-05	0.000981	CcSEcCtD
Benazepril—Photosensitivity reaction—Methotrexate—systemic scleroderma	4.4e-05	0.000979	CcSEcCtD
Benazepril—Asthenia—Mycophenolic acid—systemic scleroderma	4.4e-05	0.000978	CcSEcCtD
Benazepril—Diarrhoea—Leflunomide—systemic scleroderma	4.39e-05	0.000978	CcSEcCtD
Benazepril—Insomnia—Mycophenolate mofetil—systemic scleroderma	4.37e-05	0.000973	CcSEcCtD
Benazepril—Abdominal pain—Lisinopril—systemic scleroderma	4.36e-05	0.000971	CcSEcCtD
Benazepril—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	4.34e-05	0.000966	CcSEcCtD
Benazepril—Pruritus—Mycophenolic acid—systemic scleroderma	4.33e-05	0.000965	CcSEcCtD
Benazepril—Vomiting—Azathioprine—systemic scleroderma	4.32e-05	0.000962	CcSEcCtD
Benazepril—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	4.31e-05	0.00096	CcSEcCtD
Benazepril—Somnolence—Mycophenolate mofetil—systemic scleroderma	4.3e-05	0.000957	CcSEcCtD
Benazepril—Rash—Azathioprine—systemic scleroderma	4.29e-05	0.000954	CcSEcCtD
Benazepril—Dermatitis—Azathioprine—systemic scleroderma	4.28e-05	0.000954	CcSEcCtD
Benazepril—Flushing—Prednisone—systemic scleroderma	4.28e-05	0.000953	CcSEcCtD
Benazepril—Headache—Azathioprine—systemic scleroderma	4.26e-05	0.000948	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	4.26e-05	0.000948	CcSEcCtD
Benazepril—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	4.26e-05	0.000947	CcSEcCtD
Benazepril—Dizziness—Leflunomide—systemic scleroderma	4.25e-05	0.000945	CcSEcCtD
Benazepril—Diarrhoea—Mycophenolic acid—systemic scleroderma	4.19e-05	0.000933	CcSEcCtD
Benazepril—Constipation—Mycophenolate mofetil—systemic scleroderma	4.13e-05	0.00092	CcSEcCtD
Benazepril—Arrhythmia—Prednisone—systemic scleroderma	4.12e-05	0.000917	CcSEcCtD
Benazepril—Sweating—Methotrexate—systemic scleroderma	4.12e-05	0.000916	CcSEcCtD
Benazepril—Vomiting—Leflunomide—systemic scleroderma	4.08e-05	0.000909	CcSEcCtD
Benazepril—Alopecia—Prednisone—systemic scleroderma	4.08e-05	0.000907	CcSEcCtD
Benazepril—Hypersensitivity—Lisinopril—systemic scleroderma	4.07e-05	0.000905	CcSEcCtD
Benazepril—Dizziness—Mycophenolic acid—systemic scleroderma	4.05e-05	0.000902	CcSEcCtD
Benazepril—Rash—Leflunomide—systemic scleroderma	4.05e-05	0.000901	CcSEcCtD
Benazepril—Dermatitis—Leflunomide—systemic scleroderma	4.05e-05	0.000901	CcSEcCtD
Benazepril—Nausea—Azathioprine—systemic scleroderma	4.04e-05	0.000899	CcSEcCtD
Benazepril—Headache—Leflunomide—systemic scleroderma	4.02e-05	0.000896	CcSEcCtD
Benazepril—Agranulocytosis—Methotrexate—systemic scleroderma	4.01e-05	0.000892	CcSEcCtD
Benazepril—Asthenia—Lisinopril—systemic scleroderma	3.96e-05	0.000881	CcSEcCtD
Benazepril—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	3.95e-05	0.00088	CcSEcCtD
Benazepril—Pruritus—Lisinopril—systemic scleroderma	3.9e-05	0.000869	CcSEcCtD
Benazepril—Vomiting—Mycophenolic acid—systemic scleroderma	3.9e-05	0.000867	CcSEcCtD
Benazepril—Rash—Mycophenolic acid—systemic scleroderma	3.86e-05	0.00086	CcSEcCtD
Benazepril—Dermatitis—Mycophenolic acid—systemic scleroderma	3.86e-05	0.000859	CcSEcCtD
Benazepril—Hepatitis—Methotrexate—systemic scleroderma	3.85e-05	0.000858	CcSEcCtD
Benazepril—Headache—Mycophenolic acid—systemic scleroderma	3.84e-05	0.000854	CcSEcCtD
Benazepril—Pharyngitis—Methotrexate—systemic scleroderma	3.83e-05	0.000852	CcSEcCtD
Benazepril—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	3.82e-05	0.000851	CcSEcCtD
Benazepril—Nausea—Leflunomide—systemic scleroderma	3.81e-05	0.000849	CcSEcCtD
Benazepril—Diarrhoea—Lisinopril—systemic scleroderma	3.78e-05	0.00084	CcSEcCtD
Benazepril—Angioedema—Prednisone—systemic scleroderma	3.67e-05	0.000817	CcSEcCtD
Benazepril—Dizziness—Lisinopril—systemic scleroderma	3.65e-05	0.000812	CcSEcCtD
Benazepril—Erythema multiforme—Methotrexate—systemic scleroderma	3.64e-05	0.000811	CcSEcCtD
Benazepril—Nausea—Mycophenolic acid—systemic scleroderma	3.64e-05	0.00081	CcSEcCtD
Benazepril—Vertigo—Prednisone—systemic scleroderma	3.61e-05	0.000803	CcSEcCtD
Benazepril—Syncope—Prednisone—systemic scleroderma	3.6e-05	0.000802	CcSEcCtD
Benazepril—Tinnitus—Methotrexate—systemic scleroderma	3.59e-05	0.0008	CcSEcCtD
Benazepril—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	3.56e-05	0.000793	CcSEcCtD
Benazepril—Loss of consciousness—Prednisone—systemic scleroderma	3.53e-05	0.000786	CcSEcCtD
Benazepril—Vomiting—Lisinopril—systemic scleroderma	3.51e-05	0.000781	CcSEcCtD
Benazepril—Rash—Lisinopril—systemic scleroderma	3.48e-05	0.000775	CcSEcCtD
Benazepril—Dermatitis—Lisinopril—systemic scleroderma	3.48e-05	0.000774	CcSEcCtD
Benazepril—Asthenia—Mycophenolate mofetil—systemic scleroderma	3.47e-05	0.000772	CcSEcCtD
Benazepril—Headache—Lisinopril—systemic scleroderma	3.46e-05	0.00077	CcSEcCtD
Benazepril—Pruritus—Mycophenolate mofetil—systemic scleroderma	3.42e-05	0.000761	CcSEcCtD
Benazepril—Myalgia—Prednisone—systemic scleroderma	3.42e-05	0.000761	CcSEcCtD
Benazepril—Arthralgia—Prednisone—systemic scleroderma	3.42e-05	0.000761	CcSEcCtD
Benazepril—Anxiety—Prednisone—systemic scleroderma	3.41e-05	0.000758	CcSEcCtD
Benazepril—Alopecia—Methotrexate—systemic scleroderma	3.41e-05	0.000758	CcSEcCtD
Benazepril—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	3.31e-05	0.000736	CcSEcCtD
Benazepril—Nausea—Lisinopril—systemic scleroderma	3.28e-05	0.00073	CcSEcCtD
Benazepril—Anaphylactic shock—Prednisone—systemic scleroderma	3.28e-05	0.00073	CcSEcCtD
Benazepril—Oedema—Prednisone—systemic scleroderma	3.28e-05	0.00073	CcSEcCtD
Benazepril—Infection—Prednisone—systemic scleroderma	3.26e-05	0.000725	CcSEcCtD
Benazepril—Back pain—Methotrexate—systemic scleroderma	3.25e-05	0.000723	CcSEcCtD
Benazepril—Shock—Prednisone—systemic scleroderma	3.22e-05	0.000718	CcSEcCtD
Benazepril—Dizziness—Mycophenolate mofetil—systemic scleroderma	3.2e-05	0.000712	CcSEcCtD
Benazepril—Hyperhidrosis—Prednisone—systemic scleroderma	3.17e-05	0.000705	CcSEcCtD
Benazepril—Vomiting—Mycophenolate mofetil—systemic scleroderma	3.07e-05	0.000684	CcSEcCtD
Benazepril—Rash—Mycophenolate mofetil—systemic scleroderma	3.05e-05	0.000679	CcSEcCtD
Benazepril—Dermatitis—Mycophenolate mofetil—systemic scleroderma	3.05e-05	0.000678	CcSEcCtD
Benazepril—Headache—Mycophenolate mofetil—systemic scleroderma	3.03e-05	0.000674	CcSEcCtD
Benazepril—Vertigo—Methotrexate—systemic scleroderma	3.01e-05	0.000671	CcSEcCtD
Benazepril—Leukopenia—Methotrexate—systemic scleroderma	3e-05	0.000669	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Prednisone—systemic scleroderma	2.99e-05	0.000665	CcSEcCtD
Benazepril—Insomnia—Prednisone—systemic scleroderma	2.96e-05	0.00066	CcSEcCtD
Benazepril—Paraesthesia—Prednisone—systemic scleroderma	2.94e-05	0.000655	CcSEcCtD
Benazepril—Cough—Methotrexate—systemic scleroderma	2.93e-05	0.000652	CcSEcCtD
Benazepril—Dyspepsia—Prednisone—systemic scleroderma	2.88e-05	0.000642	CcSEcCtD
Benazepril—Nausea—Mycophenolate mofetil—systemic scleroderma	2.87e-05	0.000639	CcSEcCtD
Benazepril—Chest pain—Methotrexate—systemic scleroderma	2.86e-05	0.000636	CcSEcCtD
Benazepril—Arthralgia—Methotrexate—systemic scleroderma	2.86e-05	0.000636	CcSEcCtD
Benazepril—Myalgia—Methotrexate—systemic scleroderma	2.86e-05	0.000636	CcSEcCtD
Benazepril—Fatigue—Prednisone—systemic scleroderma	2.83e-05	0.000629	CcSEcCtD
Benazepril—Constipation—Prednisone—systemic scleroderma	2.8e-05	0.000624	CcSEcCtD
Benazepril—Anaphylactic shock—Methotrexate—systemic scleroderma	2.74e-05	0.00061	CcSEcCtD
Benazepril—Infection—Methotrexate—systemic scleroderma	2.72e-05	0.000606	CcSEcCtD
Benazepril—Thrombocytopenia—Methotrexate—systemic scleroderma	2.68e-05	0.000597	CcSEcCtD
Benazepril—Gastrointestinal pain—Prednisone—systemic scleroderma	2.68e-05	0.000597	CcSEcCtD
Benazepril—Hyperhidrosis—Methotrexate—systemic scleroderma	2.65e-05	0.000589	CcSEcCtD
Benazepril—Abdominal pain—Prednisone—systemic scleroderma	2.59e-05	0.000577	CcSEcCtD
Benazepril—Hypotension—Methotrexate—systemic scleroderma	2.56e-05	0.00057	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	2.5e-05	0.000555	CcSEcCtD
Benazepril—Insomnia—Methotrexate—systemic scleroderma	2.48e-05	0.000551	CcSEcCtD
Benazepril—Paraesthesia—Methotrexate—systemic scleroderma	2.46e-05	0.000547	CcSEcCtD
Benazepril—Dyspnoea—Methotrexate—systemic scleroderma	2.44e-05	0.000544	CcSEcCtD
Benazepril—Somnolence—Methotrexate—systemic scleroderma	2.43e-05	0.000542	CcSEcCtD
Benazepril—Hypersensitivity—Prednisone—systemic scleroderma	2.41e-05	0.000537	CcSEcCtD
Benazepril—Dyspepsia—Methotrexate—systemic scleroderma	2.41e-05	0.000537	CcSEcCtD
Benazepril—Fatigue—Methotrexate—systemic scleroderma	2.36e-05	0.000526	CcSEcCtD
Benazepril—Asthenia—Prednisone—systemic scleroderma	2.35e-05	0.000523	CcSEcCtD
Benazepril—Pruritus—Prednisone—systemic scleroderma	2.32e-05	0.000516	CcSEcCtD
Benazepril—Diarrhoea—Prednisone—systemic scleroderma	2.24e-05	0.000499	CcSEcCtD
Benazepril—Gastrointestinal pain—Methotrexate—systemic scleroderma	2.24e-05	0.000499	CcSEcCtD
Benazepril—Dizziness—Prednisone—systemic scleroderma	2.17e-05	0.000482	CcSEcCtD
Benazepril—Abdominal pain—Methotrexate—systemic scleroderma	2.17e-05	0.000482	CcSEcCtD
Benazepril—Vomiting—Prednisone—systemic scleroderma	2.08e-05	0.000464	CcSEcCtD
Benazepril—Rash—Prednisone—systemic scleroderma	2.07e-05	0.00046	CcSEcCtD
Benazepril—Dermatitis—Prednisone—systemic scleroderma	2.06e-05	0.00046	CcSEcCtD
Benazepril—Headache—Prednisone—systemic scleroderma	2.05e-05	0.000457	CcSEcCtD
Benazepril—Hypersensitivity—Methotrexate—systemic scleroderma	2.02e-05	0.000449	CcSEcCtD
Benazepril—Asthenia—Methotrexate—systemic scleroderma	1.96e-05	0.000437	CcSEcCtD
Benazepril—Nausea—Prednisone—systemic scleroderma	1.95e-05	0.000433	CcSEcCtD
Benazepril—Pruritus—Methotrexate—systemic scleroderma	1.94e-05	0.000431	CcSEcCtD
Benazepril—Diarrhoea—Methotrexate—systemic scleroderma	1.87e-05	0.000417	CcSEcCtD
Benazepril—Dizziness—Methotrexate—systemic scleroderma	1.81e-05	0.000403	CcSEcCtD
Benazepril—Vomiting—Methotrexate—systemic scleroderma	1.74e-05	0.000388	CcSEcCtD
Benazepril—Rash—Methotrexate—systemic scleroderma	1.73e-05	0.000384	CcSEcCtD
Benazepril—Dermatitis—Methotrexate—systemic scleroderma	1.73e-05	0.000384	CcSEcCtD
Benazepril—Headache—Methotrexate—systemic scleroderma	1.72e-05	0.000382	CcSEcCtD
Benazepril—Nausea—Methotrexate—systemic scleroderma	1.63e-05	0.000362	CcSEcCtD
